C. Singer

The effect of EUSOMA certification on quality of breast cancer care.

C. Sohn, J. Heil, R. Kimmig, 2015, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

The iTOP trial: Comparing immediate techniques of oncoplastic surgery with conventional breast surgery in women with breast cance - A prospective, controlled, single-center study.

M. Gnant, R. Jakesz, F. Fitzal, 2022, International journal of surgery.

Use of polysaccharide hemostatic agent (HaemoCer™) in breast cancer surgery to reduce postoperative complications: A randomised controlled trial.

G. Pfeiler, P. Krotka, M. Koch, 2022, International wound journal.

Austrian treatment algorithms in HER2-positive metastatic breast cancer: a 2022 update

M. Gnant, K. Strasser-Weippl, P. Krippl, 2022, Wiener klinische Wochenschrift.

Updated Austrian treatment algorithm in HER2+ metastatic breast cancer

E. Petru, R. Bartsch, G. Rinnerthaler, 2022, Wiener klinische Wochenschrift.

Correlation Between Preoperative Radiological and Postoperative Pathological Tumor Size in Patients With HER2+ Breast Cancer After Neoadjuvant Chemotherapy Plus Trastuzumab and Pertuzumab.

Z. Bago-Horvath, G. Pfeiler, V. Falcone, 2021, Clinical breast cancer.

Time trends (2006-2015) of quality indicators in EUSOMA-certified breast centres.

R. Mansel, C. Sohn, J. Heil, 2017, European journal of cancer.

Liver function indicators in patients with breast cancer before and after detection of hepatic metastases-a retrospective study

D. Gschwantler-Kaulich, I. Holzer, M. Marhold, 2023, PloS one.

Long-Term Outcomes of Adjuvant Denosumab in Breast Cancer.

R. Greil, J. Bergh, F. Kainberger, 2022, NEJM evidence.

Survival from breast cancer in women with a BRCA2 mutation by treatment

F. Couch, P. Møller, W. Foulkes, 2021, British Journal of Cancer.

Primary surgery versus no surgery in synchronous metastatic breast cancer: patient-reported quality-of-life outcomes of the prospective randomized multicenter ABCSG-28 Posytive Trial

R. Greil, M. Gnant, R. Exner, 2019, BMC Cancer.

Efficient leukocyte depletion by a novel microfluidic platform enables the molecular detection and characterization of circulating tumor cells Authors

E. Obermayr, R. Zeillinger, M. Krainer, 2017 .

Impact of BMI in Patients With Early Hormone Receptor–Positive Breast Cancer Receiving Endocrine Therapy With or Without Palbociclib in the PALLAS Trial

K. Gelmon, M. Gnant, C. Isaacs, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.